focus
Previous article：
At least 13 dead in Texas as scorching temps continue
Next article： Unique patient identifier: Experts argue the benefits, pitfalls
Next article： Unique patient identifier: Experts argue the benefits, pitfalls
focus
leisure time
-
Hepatitis C has a cure — but many Americans still lack access to it
2025-09-29 18:41
-
Why Novartis is going to walk from its acquisition of MorphoSys
2025-09-29 18:40
-
Adopting new red light myopia treatments may be short
2025-09-29 17:45
-
Hepatitis C has a cure — but many Americans still lack access to it
2025-09-29 16:47 -
Moonlake's readout produced a cash windfall. Risks remain
2025-09-29 16:45 -
Readout LOUD: Venture capital, Gilead, and more M&A
2025-09-29 16:19